Mahesan Subramaniam: Pomegranate Juice and Heart Health
Mahesan Subramaniam, Co-Founder of United Health Tourism, Founder and Chief Executive Officer at TRI International group, posted on LinkedIn:
“Research shows pomegranate juice could slash artery blockages by up to 30%, offering a potent natural defense for heart health.
Recent clinical research has uncovered a powerful link between daily pomegranate juice consumption and a significant boost in heart health.
Scientists found that participants who enjoyed a single cup of the juice each day experienced up to a 30% reduction in arterial blockages. This impressive outcome is driven by punicalagins, unique antioxidants found in pomegranates that aggressively combat oxidative stress and inflammation within the blood vessels. By clearing these pathways, the juice serves as a natural defense mechanism against the buildup of plaque that leads to serious cardiovascular issues.
These findings suggest that simple dietary choices can have a profound impact on long-term wellness and disease prevention. Beyond improving blood flow, the regular intake of pomegranate juice supports overall vascular integrity, offering an accessible way to manage heart health without complex medical interventions. For anyone looking to optimize their cardiovascular system, adding this nutrient-dense beverage to a balanced diet provides a scientifically backed advantage. As the medical community increasingly recognizes the power of functional foods, the pomegranate is solidifying its reputation as a vital ally for a healthy heart.
Source:
Clinical Nutrition. Pomegranate juice consumption and its effects on cardiovascular health markers. Clinical Nutrition.”
Stay updated with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion